Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S5 is a highly conserved protein component of the bacterial small ribosomal subunit (30S), essential for accurate translation and assembly of the ribosome[1][5][6][9][10]. S5 structurally interacts with rRNA and several ribosomal proteins, contributing to the formation of tRNA- and mRNA-binding sites essential for protein synthesis[1][2][4][5][7]. Mutations in S5 can affect translational fidelity, resulting in frameshifting and suppression phenotypes[2][10], and may alter susceptibility to ribosome-targeting antibiotics[1][7]. Ribosomal protein S5 is thus a validated antibacterial drug target, with several antibiotics acting through disruption of the small subunit function or structure[7][8]. While S5 is not used as a clinical biomarker and does not have known human expression, its centrality in translation makes it critical to bacterial cell viability and antibiotic response.
Inhibition of protein synthesis by locking ribosome in an inactive state or inducing misreading of mRNA through interaction with ribosome Maintenance/disruption of translational fidelity and assembly of the ribosome
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S5 (S5).